PRLD
#3242
Prelude Therapeutics Incorporated - Common Stock
3.7 4 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.86%
Variación mensual
-18.70%
Variación en los últimos 6 meses
-9.00%
Cambio anual
+199.20%
Cierres anteriores
3.8 9
Open
3.9 1
Mínimo
3.7 4
Máximo
3.9 4
Financials
- Market Capitalization 298.47 M
- Employee 79
- Founded 2016
- CEO N/A
- Website www.preludetx.com
- Headquarter Delaware, United States
- FIGI BBG00K7JY2Q6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.25
Relación precio/flujo de caja
18.38
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3207 |  CABA Cabaletta Bio, Inc. - Common Stock | 1.80 USD | -6.74% | -13.46% | -33.82% | -26.53% | 305.18 M USD | ||
| 3209 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 9.05 USD | -0.33% | +4.14% | -31.44% | -38.44% | 309.21 M USD | ||
| 3266 |  QSI Quantum-Si Incorporated - Class A Common Stock | 1.37 USD | -10.46% | +7.03% | +87.67% | -21.26% | 299.87 M USD | ||
| 3288 |  EYPT EyePoint, Inc. - Common Stock | 3.32 USD | -2.35% | +5.40% | -22.61% | -72.33% | 286.22 M USD |